Steven Pearlman, M.D., F.A.C.S Company Profile
Dr. Pearlman is a facial plastic and reconstructive surgeon based in New York City. He is dual board certified in Facial Plastic and Reconstructive Surgery as well as Head and Neck Surgery. His work spans the gamut of invasive and non-invasive procedures, including: blepharoplasty, facelifts, facial implants, forehead lifts, rhinoplasty, revision rhinoplasty - procedures for which he is renowned - IPL rejuvenation, laser skin resurfacing, lip augmentation, skin care and Botox. In 1993, Dr. Pearlman founded the New York Facial Plastic Surgery Society to promote advanced education for facial plastic surgeons in the New York Metropolitan area. He is Director of the Division of Facial Plastic Surgery at St. Luke's-Roosevelt Hospital. In addition, he is an attending surgeon at both Lenox Hill and Manhattan Eye Ear and Throat Hospitals.
News Articles
San Diego, CA (PRWEB) April 03, 2013 The Law Office of Steven M. Bishop, CFLS recently launched a newly designed website, providing a valuable online legal resource to current and potential clients...
Medgenics demonstrates Biopump technology potential as it enters inflection point
Medgenics chief executive Dr Andrew Pearlman believes the firm's Biopump technology has the promise to provide a "major change in medicine" and at last night's Proactive Investor One2One Forum he expl...
Questionable Practices From ACP: Steven Weinberger Interview
Medscape interviewed ACP CEO Steven E. Weinberger, MD, about participation in Choosing Wisely, a multisociety initiative to educate physicians and patients on recommendations against certain questiona...
OBN announces changes to board of directors
OBN announced changes to the OBN Board of Directors. Dr Steven Lee is reluctantly standing down as Chairman and his place will be taken by David Laskow-Pooley. Congratulating David on his appointment...
Medgenics reports on significant period of change as advances trials
Medgenics’ (LON:MEDG, NYSE:MDGN) quarterly results reflected a period of significant progress for the medical technology group. Research expenditure and general administrative costs rose...
Conversations with … Steven Stack, MD
(MedPage Today) -- "Conversations with ..." is a series of exclusive video interviews with leaders of medical research and policy. In this segment, George Lundberg, MD, MedPage Today Editor-at-Large,...
Steven Salzberg on Microbial Genomes, Open Access, Flu Shots and Gene Patents
Bio-IT World | Steven Salzberg, computer scientist at Johns Hopkins University, is the winner of the 2013 Benjamin Franklin Award, presented annually by the Bioinformatics Organization. He spoke to...
Omnicare Announces the Appointment of Steven Skwara as Chief Compliance Officer
CINCINNATI, September 5, 2012 - Omnicare, Inc. (NYSE: OCR) today announced Steven Skwara has been appointed Chief Compliance Officer. Mr. Skwara will oversee and lead Omnicare's corporate compliance f...
Drugs and Medications
Lipofen [Kowa Pharmaceuticals America Inc.]
These highlights do not include all the information needed to use LIPOFEN® safely and effectively. See full prescribing information for LIPOFEN®. LIPOFEN® (fenofibrate capsules, USP)Initial U.S. Ap...
PubMed Articles
Durable responses to rituximab in acquired factor VIII deficiency.
Nomenclature for factors of the HLA system, update May 2010.
Nomenclature for factors of the HLA system, update April 2010.
Nomenclature for factors of the HLA system, update June 2010.
Clinical Trials
Stevens-Johnson Syndrome Antimicrobial
Steven-Johnson's syndrome, or great multiform erythema, appears as a systemic disturbance, with skin involvement and mucous membranes, related to several factors, such as, viral or bacteri...
Efficacy of Subtenon's Block With Olive Tipped Cannula
The purpose of this study is to compare the efficacy of olive tip cannula to the standard Steven's cannula in performing subtenon's anesthesia for patients undergoing cataract surgery.
Efficacy Study of XL184 in Adults With Medullary Thyroid Cancer
The purpose of this research study is to evaluate the progression-free survival (PFS) with XL184 as compared with placebo (an inactive substance) in subjects with unresectable, locally adv...
Genetics Informatics Trial of Warfarin to Prevent Deep Venous Thrombosis (DVT)
On September 15, 2008, Acting Surgeon General Steven Galson, MD, MPH noted that blood clots contribute to the death of at least 100,000 Americans each year. Because many of these deaths o...
Type 2DM is present in the populations of almost all the countries in the world and is a significant disease burden in most countries .Evidences suggest that population in India develop Ty...
Companies
Steven Pearlman, M.D., F.A.C.S
Dr. Pearlman is a facial plastic and reconstructive surgeon based in New York City. He is dual board certified in Facial Plastic and Reconstructive Surgery as well as Head and Neck Surgery. His work s...
More Information about "Steven Pearlman, M.D., F.A.C.S" on BioPortfolio
We have published hundreds of Steven Pearlman, M.D., F.A.C.S news stories on BioPortfolio along with dozens of Steven Pearlman, M.D., F.A.C.S Clinical Trials and PubMed Articles about Steven Pearlman, M.D., F.A.C.S for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Steven Pearlman, M.D., F.A.C.S Companies in our database. You can also find out about relevant Steven Pearlman, M.D., F.A.C.S Drugs and Medications on this site too.
